Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake. Biogen, Argenx, Sanofi, and Bristol Myers ...

The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.

Senators from both parties endorsed a $400 million increase to the budget of the National Institutes of Health on Thursday ...

Facing a range of competitive and government challenges, Moderna announced layoffs Thursday affecting 10% of its workforce.

It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...

U.S. kindergarten vaccination rates inched down again last year and the share of children with exemptions rose to an all-time ...

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Eli Lilly’s blockbuster diabetes drug Mounjaro matched the ability of an older treatment to prevent major heart complications ...

Trump demanded that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the ...

Alnylam Pharmaceuticals’ new cardiovascular drug is off to a stronger-than-expected launch. The treatment, Amvuttra, brought ...

In many ways, despite what RFK Jr. and Rep. Paul Gosar claim, the Vaccine Injury Compensation Program is more friendly to ...

VC firm Frazier Life Sciences has raised a $1.3 billion fund, the firm’s largest to date and one of the few new biotech ...